ZA803051B - Novel derivatives of 3-aminopropanesulfonic acid having a reinforced activity on membrane - Google Patents

Novel derivatives of 3-aminopropanesulfonic acid having a reinforced activity on membrane

Info

Publication number
ZA803051B
ZA803051B ZA00803051A ZA803051A ZA803051B ZA 803051 B ZA803051 B ZA 803051B ZA 00803051 A ZA00803051 A ZA 00803051A ZA 803051 A ZA803051 A ZA 803051A ZA 803051 B ZA803051 B ZA 803051B
Authority
ZA
South Africa
Prior art keywords
membrane
novel derivatives
aminopropanesulfonic acid
reinforced activity
reinforced
Prior art date
Application number
ZA00803051A
Other languages
English (en)
Inventor
J Durlach
Original Assignee
Meram Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meram Lab filed Critical Meram Lab
Publication of ZA803051B publication Critical patent/ZA803051B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/02Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • C07C309/15Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton the nitrogen atom of at least one of the amino groups being part of any of the groups, X being a hetero atom, Y being any atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA00803051A 1979-05-23 1980-05-22 Novel derivatives of 3-aminopropanesulfonic acid having a reinforced activity on membrane ZA803051B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7913207A FR2457281A1 (fr) 1979-05-23 1979-05-23 Nouveaux derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee

Publications (1)

Publication Number Publication Date
ZA803051B true ZA803051B (en) 1981-06-24

Family

ID=9225819

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00803051A ZA803051B (en) 1979-05-23 1980-05-22 Novel derivatives of 3-aminopropanesulfonic acid having a reinforced activity on membrane

Country Status (18)

Country Link
US (1) US4355043A (xx)
JP (2) JPS5625146A (xx)
AT (1) AT372371B (xx)
AU (1) AU535785B2 (xx)
BE (1) BE883468A (xx)
CA (1) CA1152100A (xx)
CH (1) CH647757A5 (xx)
DE (2) DE19675017I2 (xx)
ES (1) ES491787A0 (xx)
FR (1) FR2457281A1 (xx)
GB (1) GB2051789B (xx)
GR (1) GR68547B (xx)
IT (1) IT1130455B (xx)
MA (1) MA18855A1 (xx)
MX (1) MX9203363A (xx)
NL (2) NL191789C (xx)
OA (1) OA06606A (xx)
ZA (1) ZA803051B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU193197B (en) * 1984-02-03 1987-08-28 Egyt Gyogyszervegyeszeti Gyar Preparatives regulating the growth of plants containing as reagent derivatives of n-substituated amin-prophansulphonic acid and process for production of the reagent
JPH0725771B2 (ja) * 1992-06-18 1995-03-22 財団法人生産開発科学研究所 2−アミノエタンスルホン酸亜鉛錯化合物
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
AU703540B2 (en) * 1996-03-26 1999-03-25 Meddiss, Incorporated Methods for inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
US6057373A (en) * 1997-05-22 2000-05-02 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists
US6391922B1 (en) 1998-01-13 2002-05-21 Synchroneuron, Llc Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders
US6294583B1 (en) * 1998-01-13 2001-09-25 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders
US5952389A (en) * 1998-01-13 1999-09-14 Synchroneuron Methods of treating tardive dyskinesia and other movement disorders
CN1293573A (zh) * 1998-01-13 2001-05-02 同步神经元有限责任公司 迟发性运动障碍和其它运动疾病的治疗方法
ES2209110T3 (es) * 1998-01-27 2004-06-16 Merck Sante Nuevos derivados de acidos aninoalcano sulfonicos, fosfonicos y fosfinicos, su preparacion y su uso como medicamentos.
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
FR2775188B1 (fr) 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
WO2000064420A2 (en) * 1999-04-28 2000-11-02 Queen's University At Kingston Compositions and methods for treating amyloidosis using sulphonate derivatives
US6562836B1 (en) 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
JP2008519822A (ja) * 2004-11-12 2008-06-12 ニューロケム (インターナショナル) リミテッド アミロイド関連疾患を治療するための方法およびフッ素化組成物
JP2008520647A (ja) * 2004-11-16 2008-06-19 ニューロケム (インターナショナル) リミテッド Cnsおよびアミロイド関連疾患治療のための化合物
US8044100B2 (en) * 2004-12-22 2011-10-25 Bellus Health Inc. Methods and compositions for treating amyloid-related diseases
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
ATE481094T1 (de) * 2005-12-22 2010-10-15 Kiacta Sarl Behandlung von diabetischer nephropathie
CN103787927B (zh) 2006-10-12 2017-03-01 Bhi有限合资公司 递送3‑氨基‑1‑丙磺酸的方法、化合物、组合物和载体
WO2008078176A1 (en) * 2006-12-22 2008-07-03 Bellus Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
KR100877134B1 (ko) * 2007-05-03 2009-01-09 주식회사 엔지켐 아캄프로세이트 칼슘의 제조방법
US20090082464A1 (en) * 2007-09-07 2009-03-26 Bernd Jandeleit Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
WO2009033069A1 (en) * 2007-09-07 2009-03-12 Xenoport, Inc. Simple pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
US20090099253A1 (en) * 2007-10-15 2009-04-16 Xenoport, Inc. Internally Masked Neopentyl Sulfonyl Ester Cyclization Release Prodrugs of Acamprosate, Compositions Thereof, and Methods of Use
CN101492400B (zh) * 2008-01-22 2014-03-12 北京华禧联合科技发展有限公司 一种高纯度阿坎酸钙的制备方法
DE102008048791A1 (de) * 2008-09-24 2010-03-25 Merck Patent Gmbh Neue Kristallform von Calcium-3-Acetylaminopropan-1-sulfonat
IT1392327B1 (it) * 2008-09-26 2012-02-28 Laboratorio Chimico Int Spa Nuova forma polimorfa del calcio acamprosato
CN104478766A (zh) * 2014-12-25 2015-04-01 北京华禧联合科技发展有限公司 一种制备高纯度乙酰基高牛磺酸的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3039916A (en) * 1961-03-27 1962-06-19 West Laboratories Inc Anionic iodine complexes
US3544597A (en) * 1969-06-12 1970-12-01 Rohm & Haas Process for manufacturing sulfonated amides
JPS5418714B2 (xx) * 1974-10-08 1979-07-10
FR2321285A1 (fr) * 1975-08-18 1977-03-18 Stanley Drug Products Inc Agents antifibrinolytiques
FR2384751A1 (fr) * 1977-03-23 1978-10-20 Francaise Coop Pharma Nouveaux derives de la taurine a activite neuro-musculaire renforcee
US4233229A (en) * 1978-01-03 1980-11-11 Gaf Corporation Preparation of salt-free N-acyl taurines

Also Published As

Publication number Publication date
GB2051789B (en) 1983-04-27
CH647757A5 (fr) 1985-02-15
BE883468A (fr) 1980-11-24
JPH0317825B2 (xx) 1991-03-11
MA18855A1 (fr) 1980-12-31
NL970003I1 (nl) 1997-04-01
CA1152100A (en) 1983-08-16
ATA274580A (de) 1983-02-15
FR2457281A1 (fr) 1980-12-19
AT372371B (de) 1983-09-26
DE19675017I2 (de) 2001-04-26
DE3019350C2 (xx) 1989-11-30
DE3019350A1 (de) 1980-12-04
JPS5625146A (en) 1981-03-10
JPH0524135B2 (xx) 1993-04-06
IT1130455B (it) 1986-06-11
FR2457281B1 (xx) 1983-10-07
AU5869780A (en) 1980-11-27
ES8101042A1 (es) 1980-12-16
NL8002997A (nl) 1980-11-25
NL191789B (nl) 1996-04-01
OA06606A (fr) 1981-08-31
ES491787A0 (es) 1980-12-16
MX9203363A (es) 1992-07-01
GR68547B (xx) 1982-01-18
NL191789C (nl) 1996-08-02
NL970003I2 (nl) 1997-08-01
JPH03148219A (ja) 1991-06-25
GB2051789A (en) 1981-01-21
AU535785B2 (en) 1984-04-05
IT8067807A0 (it) 1980-05-22
US4355043A (en) 1982-10-19

Similar Documents

Publication Publication Date Title
ZA803051B (en) Novel derivatives of 3-aminopropanesulfonic acid having a reinforced activity on membrane
ZA791109B (en) Carbamic acid derivatives
GB2090595B (en) Threo-3-amino-2-hydroxybutanoylacetice acid derivatives
ZA781697B (en) New derivatives of taurine having a reinforced neuro-muscular activity
GB2016001B (en) Phenylacetic acid derivatives
BE887487A (fr) Utilisation de composes a activite nootropique
GB2022073B (en) Derivatives of 5-nitro-imidazole with anti-protozoic activity
ZA773739B (en) New 16-s-acyl derivatives of fusidic acid
GB2083464B (en) N-methanesulfonic acid derivatives of istamycin a or b andproduction thereof
AU515286B2 (en) Derivatives of 3-sulphamoyl 5-pyrrolyalkylbenzoic acid
GB2016004B (en) U-naphthyl-acetic acid derivatives
GB2037283B (en) -aryloxy-cyclohexylacetic acid derivatives
RO73018A (ro) Procedeu pentru conversia enzimatica a unor peniciline la acid 6-aminopenicilanic
GB2042511B (en) -lactone derivatives of 2-hydroxy-cyclopentane-carboxylic acid
JPS5592362A (en) Manufacture of percarboxylic acid solution
JPS54117448A (en) Salt of nnacylaminohydroxy naphthalene sulfonic acid
GB1516271A (en) Glycyrrhetinic acid derivatives
GB2026485B (en) Thiopropanoylamino acid derivatives
JPS5615263A (en) Manufacture of percarboxylic acid
JPS5362817A (en) Salts of glycyllysinic acid
GB8521035D0 (en) Preparing glutaconic acid derivatives
AU492025B2 (en) Derivatives of aminoethylcyclohexane-carboxylic acid
JPS5214743A (en) Production of toluene sulphonic acid derivatives
JPS52153950A (en) Production of aminoo hydroxyynaphthalene sulphonic acid
JPS54122056A (en) Error signal processer